Chapter 6: Genetic Disorders Pathology

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we are taking on what I affectionately call the blueprint chapter.

That is a perfect name for it.

We're cracking open chapter six of the USMLE step one lecture notes on pathology, specifically the 2017 edition.

The title is genetic disorders, which, you know, sounds a little dry.

It does.

It sounds academic.

But honestly, this is the operating system of the human body we're talking about.

It really is.

And it's a beast of a chapter, but it's so foundational.

When we talk about pathology, usually we're talking about wear and tear or infections or things breaking down over time.

Right, external factors.

Here we are talking about errors in the initial code.

The building blocks are flawed before the foundation is even poured.

It's a completely different way of thinking about disease.

Exactly.

And our mission today is to take this incredibly high yield material, which can feel like just a telephone book of syndromes, and really decode it.

Make sense of it.

We are going to move logically,

starting from massive visible disasters, the chromosomal abnormalities, and then zoom in all the way to

single letter typos in the DNA code.

It's all about scale.

We're talking trisomies, deletions, Mendelian rules, and even those weird outliers like genomic imprinting.

It's all in here.

And we are going to follow the roadmap exactly as the source material lays it out.

The goal is not just to memorize that gene X causes disease.

Why?

Because that's brittle knowledge.

It doesn't stick.

It doesn't.

We need to understand the mechanism.

Why does an extra chromosome cause heart defects?

Why does a missing enzyme turn cartilage black?

If you get the mechanism, you don't have to memorize the list.

The list becomes logical.

So to you listening right now, whether you're a med student drowning in flashcards or just someone fascinated by the sheer fragility of biology, we've got you.

We break this down so it sticks.

So let's start at the macro level, section one of the chapter.

Disorders involving an extra autosome, the trisomies.

Right.

And just to be clear, autosome just means the non -sex chromosome.

So chromosomes one through 22.

And the most famous one, the one everyone thinks they know, is of course Down syndrome, trisomy 21.

Yeah, that's the prototype for this category of disease.

But the text dives deeper than just saying it's an extra chromosome.

It actually starts by breaking down the karyotype.

The notation means is you count the chromosomes, you get 47 instead of the usual 46.

You identify the sex chromosomes, XX or XY, and the plus 21 tells you exactly which chromosome is the extra one.

And epidemiology wise, this is the most common chromosomal disorder.

But there is a massive correlation here that we just cannot ignore.

Maternal age.

Maternal age.

It's everything.

It really is.

It's one of the most dramatic graphs in all of medicine.

The risk is relatively low for a mother in her twenties, but then the curve it just shoots upward.

That's the number the book gives.

It's pretty stark.

By the time a mother is age 45, the incidence rises to one in 25 live births.

One in 25.

That is incredibly frequent in the world of genetic disorders.

It underscores just how much the aging process of oocytes of the eggs contributes to this.

OK, but here is where we need to get technical.

And this is where the points are on exams.

How does that extra chromosome actually get The source lists three distinct mechanisms, and the percentages really matter.

They do.

The big one, the main cause, is meiotic non -disjunction.

It counts for 95 % of cases.

The vast majority.

And to picture this, you have to go back to biology 101.

Think about the egg cells forming in the ovary.

During meiosis, the chromosome pairs are supposed to be pulled apart.

One copy goes left, one goes right into the daughter's cells.

A clean separation.

A clean separation.

In non -disjunction, they get sticky.

They fail to separate.

So both copies of chromosome 21 get pulled into the same egg cell.

The other cell gets none.

So you end up with one egg that has an extra chromosome 21, and another that has no chromosome 21 at all.

Exactly.

And that second egg, if fertilized, isn't viable.

But the first one, the one with 24 chromosomes instead of 23,

if that gets fertilized by a normal sperm carrying its own copy of 21, suddenly you have a zygote with three.

Two from mom, one from dad.

And that's your trisomy.

That's your trisomy.

And that's the random age -related error that accounts for 95 % of Down syndrome.

Okay, so that's the standard cause.

But then there's this 4 % slice of the pie called Robert Soni and translocation.

This one always trips people up.

It does, because it involves inheritance in a way that non -disjunction typically doesn't.

It can run in families.

It introduces the idea of a carrier.

A balanced or silent carrier, yeah.

So this involves what we call the acrocentric chromosomes.

Can you define that for us?

Sure.

An acrocentric chromosome is just one that's really lopsided.

The centromere, that little pinched part in the middle, is way off to one end.

So you have a really long arm with all the important genes.

And then these tiny little, almost useless short arms, chromosomes 13, 14, 15, 21, and 22 are the ones.

So what happens in the translocation?

Well, let's use the common example.

A 14, 21 translocation.

In a parent, chromosome 14 and chromosome 21 both break near their centromeres.

Then they get stuck together the wrong way.

The two long arms fuse, forming one giant super chromosome.

And the two tiny short arms also fuse, but they contain basically no essential genetic material.

So that little fragment just gets lost.

The cell doesn't miss it.

So the parent, the carrier, now has 45 chromosomes.

Exactly.

If you did their karyotype, you'd count 45.

But, and this is the key, they have a normal amount of genetic material.

They didn't lose anything important.

So they are phenotypically completely normal.

They have no idea they're a carrier.

Until they have children.

That's where the problem arises.

When that parent makes their eggs or sperm, they can pass on that giant fused 14, 21 chromosome, plus their normal separate copy of 21.

So if that gamete gets fertilized, the baby ends up with two normal copies of 14, one from each parent.

But for 21, they get one from the healthy parent, and they get the translocated 14, 21, and the normal 21 from the carrier parent.

So they have three copies worth of chromosome 21 material.

Correct.

Functionally, it's trisomy 21.

And this is why, if you see a very young mother, say 22 years old with a baby with Down syndrome,

you can't just assume it was a random non -disjunction event.

You have to suspect this.

You have to.

You should check her karyotype and the father's to see if one of them is a carrier.

It has huge implications for genetic counseling for future pregnancies.

Okay, that makes sense.

Then there's the final 1%, mosaicism.

The book describes this as having two or more populations of cells in one individual.

This is the sliding doors moment of genetics.

It really is.

What do you mean?

Well, in this case, fertilization was perfect.

The egg had 23 chromosomes.

The sperm had 23.

The zygote was a normal 46.

The blueprint was correct.

Okay, so where does it go wrong?

It goes wrong after fertilization during one of the early cell divisions of the embryo, a mitotic error.

One cell divides and non -disjunction happens then.

So from that point on, you have two cell lines developing side by side.

One normal and one with trisomy 21.

Exactly.

So you end up with a person who is a patchwork.

Some of their cells have 46 chromosomes.

Some have 47.

And I assume the severity of the disease, the clinical presentation depends entirely on the ratio.

The ratio and the distribution, yes.

If the error happens very early, more tissues will be affected.

If it happens later, it might be more localized.

These individuals often have milder features of Down syndrome.

So three very different ways to get to the same clinical endpoint.

Now let's visualize the patient.

The text references figure 6 -1, which shows the classic features.

If you were doing a physical exam on a newborn,

what are the high -yield findings?

You're looking for a constellation of features.

First, the face.

There's a characteristic flat facial profile, a low -bridge nose,

and prominent epicanthal folds.

Those are the skin folds at the inner corner of the eyes.

Correct.

It gives the eyes an upward slant.

And if you get out your ophthalmoscope and look closely at the iris, you might see brush field spots, little white or grayish spots speckled on the periphery.

They're aggregates of connective tissue.

What about the overall body structure?

Hypotonia is a big one.

They're often described as floppy babies.

They have low muscle tone.

OK.

You'll also see a broad short neck, often with excess skin at the back, what's called redundant neutral skin.

Then you check the hands.

The simian crease.

The simian crease, or single transverse palmar crease.

A single line running all the way across the palm instead of the usual two.

Does that specific to Down syndrome?

It's not pathognomonic.

You can see it in the general population, but it's present in about half of individuals with Down syndrome, so it's a strong clue.

And on the feet, there's often a noticeable gap between the first and second toes, sometimes called the sandal gap.

OK.

So those are the external signs.

But as we know, it's the internal pathology that really determines the morbidity and life expectancy.

Right.

The heart defects here are very specific.

They are.

This is incredibly high yield.

We aren't just talking about a small hole in the heart.

The most characteristic defect is an endocardial cushion defect.

Break that down for us.

What are the endocardial cushion defects?

Think of them as the developmental scaffolding in the very center of the fetal heart.

They are responsible for separating the atria from the ventricles and for forming the mitral and tricuspid valves.

So they build the central cross of the heart.

Perfectly put.

If they fail to develop and fuse properly, which they often do in trisomy 21, you get a huge hole right in the middle of the heart.

The formal name is a complete atrioventricular canal defect.

So essentially, the four chambers are no longer separate.

Exactly.

It allows for free mixing of oxygenated and deoxygenated blood between all four chambers.

From a hemodynamic standpoint, it's a nightmare.

It leads to severe heart failure very early in life, if not surgically corrected.

The gut also has some very classic issues.

The text mentions the famous double bubble sign.

Ah yes, duodenal atresia.

This is another one to burn into your memory.

For some reason, in trisomy 21, the first part of the small intestine, the duodenum, fails to form a proper tube.

It's just blocked.

And the double bubble on an x -ray is?

It's air in the stomach.

That's the first bubble.

And air in the proximal part of the duodenum, right before the blockage.

That's the second bubble.

And there's no air downstream from there because nothing can get through.

The book also lists her sprung disease.

Yes, another association.

That's where the nerve cells are missing from the end of the colon, so it can't relax to pass stool.

You also see intestinal stenosis and umbilical hernias more frequently.

And the long -term risks are just as serious.

The text drops a terrifying statistic about leukemia.

Yes, a 15 to 20 -fold increased risk of acute lymphoblastic leukemia, or AL.

That is a huge increase.

It is, and there's also a risk of a specific type of childhood leukemia called acute megakaryoblastic leukemia.

There's something about that extra chromosome 21 that just predisposes these hematopoietic stem cells to malignant transformation.

And then there's the neurological guarantee.

The book says it's a virtual certainty.

It is.

By age 40, virtually all individuals with Down syndrome develop the neuropathological changes of Alzheimer disease.

That seems incredibly young.

Is it the same disease process, just accelerated?

It is, and we think we know why.

It comes down to gene dosage.

What the key genes involved in Alzheimer's is the amyloid precursor protein, or APP gene.

And let me guess where it's located.

It's located on chromosome 21.

So since they have three copies of that gene, their neurons produce about 1 .5 times the normal amount of APP for their entire lives.

Which leads to more amyloid beta plaque formation.

Exactly.

The plaques and tangles accumulate much, much earlier in life.

It's a tragic but fascinating example of how a quantitative change in gene expression can lead to a qualitative disease state.

The median life expectancy, the book notes, is now 47 years, which is a huge improvement, but still highlights the severity.

OK.

That is a very thorough look at trisomy 21.

Let's move on to the other trisomies mentioned.

These are much more severe.

Let's look at trisomy 18, Edwards syndrome.

Edwards is devastating.

Like Down syndrome, it's usually caused by meiotic non -disjunction and is associated with advanced maternal age.

But the phenotype is just.

It's much more severe.

Survival beyond the first year is rare.

The book has figure 6 -2 showing a typical infant.

What are the key features?

Well, there is profound intellectual disability.

And you see a very characteristic head shape.

A prominent occiput, so the back of the skull sticks out, paired with a very small jaw or micrognathia.

The ears are often low set and malformed.

And the hands and feet have very specific exam clues that show up on tests.

Absolutely.

The hands show overlapping flexed fingers.

It's a very specific pattern.

The index finger crosses over the middle finger, and the pinky finger crosses over the ring finger.

It's a very tight clenched fist that's hard to straighten.

And the feet.

They have rocker bottom feet.

The sole of the foot is convex, rounded like the bottom of a rocking chair, instead of having a normal arch.

The text also mentions limited hip abduction as a finding.

And the prognosis is so poor because of internal defects.

Yes.

Very severe congenital heart disease and renal malformations are almost universal.

The combination is just not compatible with long -term life.

Then finally, in this section, we have Trisomy 13, Patao syndrome.

Patao is another one with a very poor prognosis, again linked to non -disjunction and maternal age.

The book highlights defects right down the midline of the body.

That's the key organizing principle for Patao.

Think about the center line of the developing embryo.

That's where you see the problems.

So you get cleft lip and door, cleft palate.

Midline facial defect.

Yes.

And then inside the head, you see microcephaly, small head, and the most severe defect of all, holoprosencephaly.

That's where the forebrain doesn't split, is that right?

Correct.

The brain fails to divide into two distinct cerebral hemispheres.

It can range in severity, but it's a catastrophic malformation of the central nervous system.

What other signs are classic for Patao?

Polydactyly, which is extra fingers or toes, is very common.

And internally, again, you see severe cardiac defects and renal abnormalities like cystic kidneys.

The combination of the severe brain and heart defects is what makes the prognosis so heartbreakingly poor.

OK, let's shift gears.

That covers extra chromosomes.

Now the text moves to missing pieces.

Section 2, chromosomal deletions.

The chapter leads with Cretochot syndrome.

Cry of the cat.

Right.

What's the genetic defect there?

It's a deletion of the short arm of chromosome 5.

The notation is 5p.

And the name obviously comes from a very specific clinical sign.

It does.

These infants have a high -pitched mewing cry that sounds remarkably like a cat.

It's due to an abnormal development of the larynx.

It's very distinctive.

And what are the other features?

They have significant intellectual disability,

microcephaly, and often congenital heart disease as well.

Then the chapter introduces micro deletions.

These are sneaky, it says, because you can't see them on a standard karyotype.

Right.

A karyotype can only detect large -scale changes, a whole missing chromosome, a big deletion.

These are too small.

You'd need a more sensitive molecular technique like VESH or fluorescence in situ hybridization to find them.

The text highlights two specific high -yield addresses on the genome.

First, 13Q14.

This is the locus for the retinoblastoma gene RB1.

If a baby is born with a micro deletion of this region, they've lost one copy of a critical tumor suppressor gene.

So they're predisposed to cancer.

Exactly.

They have a much higher risk of developing retinoblastoma, a tumor of the eye.

And the second one is a very complex acronym, the Wagyura complex at 11p13.

Can you break down that acronym for us?

Sure.

Wagyura stands for the constellation of findings.

W is for Wilms tumor, which is the most common kidney cancer in children.

OK.

A is for aniridia, which is the complete or partial absence of the iris, the colored part of the eye.

G is for genitourinary anomalies.

And R stands for, well, the text uses the older term mental retardation, but the modern term is intellectual disability.

So these micro deletions really show how just a few missing genes can have these massive systemic effects.

Precisely.

All right, that brings us to section three.

Disorders involving sex chromosomes.

We are leaving the autosomes behind.

These are the disorders involving X and Y.

And the first one up is Kleinfelter syndrome.

The karyotype is 47XXY.

So phenotypically, this is a male, because the presence of a Y chromosome is what determines maleness.

Correct.

The SRY gene on the Y chromosome is the testes determining factor, so they are male.

But that extra X chromosome throws a huge wrench in the hormonal works.

Kleinfelter is a leading cause of male hypogonadism.

The hormonal profile here is a classic example of a feedback loop failure.

Can you walk us through that?

Sure.

So the brain, specifically the pituitary gland, is trying to get the testes to work.

It pumps out follicle stimulating hormone, FSH, and luteinizing hormone, LH.

It's basically screaming at the testes, make testosterone, make sperm.

So FSH and LH levels will be high.

Exactly.

They're elevated because the pituitary is getting no negative feedback.

But the problem is, in the tests themselves, they are atrophied and fibrotic, a condition called testicular atrophy.

They can't respond to the signals.

So testosterone remains low.

Right.

And because of that low testosterone and the effects of having two X chromosomes, you get a higher ratio of estrogen to testosterone.

And the clinical picture reflects that imbalance.

Perfectly.

You see what's called a unicoid body habitus.

They tend to be tall with unusually long arms and legs.

You see gynecomastia, which is breast development in males.

A high -pitched voice.

And female hair distribution with sparse body and facial hair.

And crucially for many patients.

They are infertile.

The testicular atrophy leads to isospermia, a lack of sperm.

This is often how they're diagnosed when they seek help for infertility as adults.

Okay, so that's the male side.

On the flip side of that, we have Turner syndrome.

The karyotype is 45X, a female missing her second X chromosome.

And this condition teaches us something fundamental.

You need two X chromosomes for normal ovarian development and eugenesis.

Without that second X, the ovaries can't survive.

They undergo accelerated apoptosis.

So they just disappear.

They degenerate into what are called streak ovaries.

Just thin strips of fibrous connective tissue with no follicles, no eggs.

So no eggs means no puberty.

Correct.

They have primary amenuria.

They will never start their period naturally.

This combined with short stature is the classic presentation in an adolescent.

Figure six to four in the book paints a very distinct picture of a patient with Turner syndrome.

It does.

Short stature is the most consistent finding.

Then you have what's called a shield chest, which is a broad chest with widely spaced nipples.

And the neck is also very characteristic.

Yes, webbing of the neck or cystic hygroma in infancy.

This is a flap of skin that stretches from behind the ear down to the shoulder caused by lymphatic obstruction in utero.

And that lymphatic issue causes swelling elsewhere, right?

Yes.

You see peripheral lymphedema, especially in newborns.

They're often born with swollen hands and feet, also looked at the elbows.

They often have cubitus valgus, where the forearm angles away from the body more than usual.

The book also mentions small fingernails.

And what about the heart?

There's a very high yield cardiac association here.

There is.

Productal correction of the aorta.

A narrowing of the aorta.

A significant narrowing located just before the ductus arteriosus.

This causes high blood pressure in the arms and low blood pressure in the legs.

You also frequently see a bicuspid aortic valve instead of the normal tricuspid one.

The text adds a warning about mosaicism here too.

It's not always a simple 45x karyotype.

No, and this is a clinically important point.

Some individuals are mosaics, meaning they have some normal 46xx cells.

But the dangerous scenario is a 45 ,000x46xy mosaic.

Why is that dangerous?

Because you have a female phenotype, but you have Y chromosome material present in some cells.

Those street ovaries, which have this Y chromosome material, are at a very high risk of developing a tumor called agonotoblastoma.

So they often recommend removing the street gonads in those patients.

Prophylactically, yes.

And this whole discussion really leads us nicely into the next section in the chapter, section four.

Disorders of sexual development or DSD.

The text starts by basically asking a very fundamental question.

What is sex?

It sounds philosophical, but clinically it's a very practical categorical question.

The book breaks it down into four definitions that have to be considered separately.

What are they?

First, there's karyotypic or genetic sex.

That's your chromosomes, XX versus XY.

Second is gonadal sex.

Do you have ovarian tissue or testicular tissue?

Third is ductal sex, which internal plumbing developed.

The malaria ducts, which become the uterus and fallopian tubes.

Or the wolfian ducts, which become the vase deference.

And fourth is phenotypic sex.

What do the external genitalia look like?

And in DSDs, these four definitions don't all align.

Exactly.

There's a mismatch somewhere along that chain of development.

The text mentions a very rare condition called ovo -testicular disorder.

It is extremely rare.

The karyotype is usually 46XX.

And by definition, this person has both ovarian and testicular tissue.

It's a histological diagnosis.

You have to see both under a microscope.

So they might have an ovo -testis, which is a mix of both.

Or maybe one ovary, one testis.

Correct.

The external genitalia are almost always ambiguous.

And then the text introduces the more modern terms.

46XXDSD and 46XYDSD.

Right.

These replace the old somewhat pejorative terms like female pseudohermaphrodite.

It's a much more precise and respectful way to classify these conditions.

So what does 46XXDSD mean?

It means the person is genetically female, 46X, and usually has ovaries.

But their external genitalia are masculinized or virilized.

And what would cause that?

The most common cause is exposure to high levels of androgens in the womb.

The classic example is congenital adrenal hyperplasia, or CAH, where the fetus's own adrenal glands overproduce androgens.

OK, so the opposite would be 46XYDSD.

Exactly.

Genetically male, 46XY, but the external genitalia look female or are ambiguous.

This happens if the testis don't form correctly.

Or if the body can't make testosterone, or like in androgen insensitivity syndrome, the body can't sense the testosterone that's being made.

This is a complex area.

Before we move on from sex chromosomes, we have to hit the in a nutshell box regarding Lyon's hypothesis.

This is the concept of X inactivation.

This is such a fundamental, elegant piece of biology.

It solves the dosage problem.

What do you mean the dosage problem?

Well, females have two X chromosomes and males have one.

The X chromosome has over a thousand genes on it.

If females express all the genes from both of their Xs, they'd have double the dose of all those proteins compared to males.

And that would be lethal.

So nature has to level the playing field.

It has to.

So very early in embryonic development in every single cell of a female embryo, one of the two X chromosomes is randomly inactivated.

They just get shut off.

Completely.

It gets super condensed into this little knot of heterochromatin called a bar body, which you can actually see pressed up against the nuclear membrane under a microscope.

And it's random which one gets turned off, maternal or paternal.

Totally random.

In one cell, mom's X might stay active.

In the cell right next door, dad's X might be the active one.

This means that biologically, all females are mosaics for their X chromosome.

That explains why female carriers for X -linked diseases, like Duchenne muscular dystrophy, can sometimes have mild symptoms.

Exactly.

It depends on what percentage of their muscle cells happen to inactivate the good X versus the bad X.

It's all up to chance.

That's a fascinating concept.

Okay, let's take a breath.

We are about to enter the biggest section of the chapter, section five.

Mendelian disorders.

Single gene mutations.

This is where we zoom in from the chromosomal level down to the level of the DNA sequence itself.

We aren't looking at chromosomes under a microscope anymore.

We are looking at the A's, T's, C's, and G's.

The text starts by outlining the basic types of mutations.

Let's quickly review those.

Point mutations.

A single letter swap.

A C becomes a T, for example.

And this can have three different outcomes.

If the new codon still codes for the same amino acid, thanks to the redundancy of the genetic code, then it's a synonymous or silent mutation.

Nothing changes.

If it changes the amino acid.

That's a missense mutation.

That's what causes sickle cell disease.

One amino acid swap changes the entire property of the hemoglobin protein.

And the worst case scenario for a point mutation.

This is a nonsense mutation.

That's where the single letter change accidentally creates a stop codon right in the middle of the gene.

So the ribosome just stops reading and the protein gets chopped in half.

It's usually completely non -functional.

And then there are frame shift mutations.

Those are devastating.

The genetic code is read in groups of three, right?

A codon.

A frame shift is when you insert or delete one or two bases.

So it's not a multiple of three.

Right.

And that shifts the entire reading frame.

Every single codon after that point is now wrong.

The protein turns into complete gibberish until it hits a random stop codon.

And the location of the mutation matters too, not just the type.

Oh, absolutely.

A mutation in a coding region affects the protein structure and function.

But a mutation in a promoter or enhancer region might leave the protein sequence intact, but completely mess up how much of it gets made.

That's our foundation.

Now, table 6 -1 is the holy grail for exams.

It compares autosomal recessive versus autosomal dominant inheritance.

Let's break down the logic so we don't have to just memorize the table row by row.

Start with autosomal recessive.

The key concept for autosomal recessive disorders is that they usually involve a broken enzyme.

Think enzymes.

Why enzymes?

Because enzymes are catalytic.

They're so efficient that usually, having just 50 % of the normal amount, which is what a carrier with one good gene and one bad gene has, is enough to get the job done.

You don't get sick.

You have a margin of safety.

A huge margin of safety.

You only run into trouble when you have two bad copies of the gene, meaning you have zero functional enzyme.

That's why it's recessive, and that's why it often skips generations.

And the other features listed.

They tend to have an early onset, often in infancy or childhood, and penetrance is usually complete.

If you have the two bad genes, you are going to have the disease.

It's a very uniform presentation.

Okay, now let's contrast that with autosomal dominant.

For dominant, think structure.

These disorders usually involve structural proteins like collagen or receptors.

Why does that make them dominant?

Well, think about building a wall.

If 50 % of your bricks are crumbling and defective, the whole wall is going to be weak.

You can't compensate for that.

You only need one bad gene to mess up the whole structure.

It's called a dominant negative effect.

That makes sense.

And the presentation.

It tends to have a later onset, often in adulthood, and a key feature is incomplete penetrance and variable expressivity.

Incomplete penetrance means you can have the bad gene, but show no signs of the disease.

Variable expressivity means that among family members who all have the gene, some might have a very severe case, while others have a very mild one.

It's much less predictable than recessive disorders.

Okay, that's a brilliant framework.

Let's apply it.

The chapter dives into specific autosomal recessive disorders.

The big one, cystic fibrosis.

CF, the most common lethal genetic disorder in the Caucasian population.

The defect is in the CFTR gene on chromosome 7.

And what is CFTR?

It is a chloride ion channel.

It's a protein that sits in the membrane of epithelial cells and pumps chloride ions out.

And the specific mutation mechanism described here is really fascinating.

It's not a simple nonsense mutation.

It's Delta F508.

Right.

This is the most common mutation by far.

And what it means is there is a deletion of three base pairs that results in the loss of a single amino acid phenylene, abbreviated F at position 508 of the protein.

So it's just missing one brick out of thousands.

Exactly.

And here is the real tragedy of this mutation.

The protein that is made is actually functional.

If you could somehow get it to the cell surface, it would work as a chloride channel.

But it doesn't get there.

It doesn't.

Because it's missing that one piece, it folds just slightly incorrectly.

And the cell has a very strict quality control system in the endoplasmic reticulum.

It sees this misfolded protein, flags it for destruction, and the proteasome chews it up.

It's a recall on a perfectly good part.

A recall on a part with a tiny cosmetic flaw so the channel never reaches the surface.

And with no chloride transport out of the cell, sodium and water don't follow.

And the secretions become thick and dehydrated.

Thick, viscous, and sticky.

And that is the root of all the pathology in cystic fibrosis.

So let's trace that pathology through the body,

the lungs.

The thick mucus clogs the airways.

It's a perfect breeding ground for bacteria.

So you get recurrent chronic pulmonary infections, particularly with staph aureus and each influenza early on.

And then ominously with pseudomonas aeruginosa later.

And the pancreas.

Same story.

The thick secretions plug up the pancreatic ducts.

The digestive enzymes can't get out into the intestine.

So the pancreas digests itself, leading to fibrosis and atrophy.

Which has two consequences.

Right.

No digestive enzymes means you can't absorb fat.

So you get steteria fatty, stools, and deficiencies of the fat -soluble vitamins, A, D, E, and K.

And eventually, the endocrine part of the pancreas is destroyed too, leading to diabetes.

The book also points out that CF kind of breaks the rules we just set up.

It does.

I said recessive disorders are usually enzymes, but CFTR is a channel which is more like a receptor that's usually a dominant trait.

And I said recessive disorders have a uniform presentation, but CF has incredibly wide clinical variation.

It really is the exception that proves the rules.

And how is it diagnosed?

The classic diagnostic test is the sweat chloride test.

Because the CFTR channel is also needed to reabsorb chloride from sweat, in CF patients, the salt can't get back into the body.

So they have salty sweat.

Very salty sweat.

That's the diagnostic hallmark.

The book also mentions that male infertility is nearly universal due to absence of the vosa dofans.

Okay.

Let's move to the next recessive disorder.

Vinal catenuria, or PKU.

This is a classic inborn error of metabolism.

It's a deficiency of the enzyme phenylenine hydroxylase.

And its job is to?

To convert the amino acid phenylenine into another amino acid, tyrosine.

So if the enzyme is broken, two things happen.

Exactly.

First, the substrate, phenylenine, builds up to toxic levels in the blood.

And phenylenine in high concentrations acts as a neurotoxin.

This is what causes severe irreversible intellectual disability by about six months of age if it's not caught.

And the second thing, you stop making the product tyrosine.

Why does that matter visibly?

Because tyrosine is the precursor for melanin, the pigment that gives color to our skin and hair.

So with low tyrosine levels, you get low melanin.

These kids are typically very pale with light skin, blonde hair, and blue eyes.

And what about the characteristic smell?

That's the musty or mousy odor.

It's caused by the buildup of phenylenine metabolites

that are excreted in the urine and sweat.

Fortunately, we screen for this at birth in every state.

We do.

And the treatment is purely dietary, a lifelong restriction of phenylenine.

This means avoiding high protein foods and, importantly, the artificial sweetener aspartame, which is made of phenylenine.

The text adds a note about maternal PKU.

Yes, this is critical.

If a woman with PKU doesn't adhere to her diet during pregnancy, her high phenylenine levels cross the placenta and act as a teratogen, causing severe damage to the developing fetus, even if the fetus itself doesn't have PKU.

OK, next up is alcaptinaria, also known as okrinosis.

Another enzyme deficiency.

This time, it's homogenetic acid oxidase, which is part of the same pathway that breaks down phenylenine and tyrosine.

So the substrate, homogenetic acid, builds up.

It does.

And this acid has a weird property.

It loves to bind to collagen and other connective tissues.

And when it polymerizes, it turns into a dark black pigment.

To get black tissues.

You get black cartilage.

You can see it in the ears and the nose.

It also deposits in the large joints, leading to a severe early onset degenerative arthritis.

And the classic sign you might see in the lab.

If you leave a urine sample from a patient sitting on the counter, it will gradually turn black as the homogenetic acid oxidizes in the air.

Next on the list, albinism.

This is a deficiency of the enzyme tyrosinase.

This enzyme is needed for the first step in melanin synthesis from tyrosine.

No tyrosinase, no melanin, anywhere.

What's the major risk for these individuals?

Skin cancer.

Without the UV protection of melanin, they are at an extremely high risk for basal cell and squamous cell carcinomas from sun exposure.

Okay, now for a group of disorders.

The glycogen storage diseases.

The text lists three important ones.

Let's start with type I, von Gierke disease.

This is a deficiency of glucose 6 -phosphatase.

This is the enzyme in the liver that does the final step of breaking down glycogen to release free glucose into the blood.

So the liver can take in glucose and store it as glycogen, but it can't release it.

Precisely.

So the glycogen just piles up, leading to a massively enlarged liver or epatomegaly.

And because the liver can't release glucose between meals, these patients get severe life -threatening hypoglycemia.

Next, type II, Pompe disease.

Pompe is unique because it's a lysosomal storage disease.

The enzyme that's deficient is a lysosomal enzyme, about 1 -V4 -glucosidase.

So glycogen builds up inside the lysosomes of all cells.

And the organ that really suffers is?

The heart.

The mnemonic is Pompe affects the pump.

You get massive cardiomegaly.

The heart muscle gets packed with glycogen and fails.

These infants typically die of heart failure by the age of two.

And type V, McGardal disease.

McGardal is a deficiency of muscle glycogen phosphorylase.

This is the enzyme that starts the breakdown of glycogen and skeletal muscle for energy.

So this is purely a muscle problem.

Yes.

The liver is fine.

They get severe, painful muscle cramps and fatigue with exercise because their muscles can't access their stored fuel.

Okay.

That brings us to the big category of lysosomal storage diseases.

Detailed in table 6 -2.

The concept is simple, as you said.

The lysosome is the cell's trash compactor.

The enzyme is the crusher.

If the crusher for a specific type of trash breaks, that trash piles up and the cell swells up and becomes dysfunctional.

Perfect analogy.

Let's start by differentiating the two that everyone mixes up.

Tay -Sachs and Neiman Pick.

They both can present with the cherry red spot on the retina.

They both are more common in Ashkenazi Jewish populations.

They both cause progressive neurodegeneration.

How do you tell them apart at the bedside?

You feel the belly.

That's the key.

In Tay -Sachs, which is a deficiency of the enzyme hexosaminidase A, the substrate that builds up GM2 ganglioside accumulates almost exclusively in neurons.

So it's a CNS disease.

Primarily.

The liver and spleen are normal size.

There is no hepatosplenomegaly in Tay -Sachs.

And Neiman Pick.

Neiman Pick is a deficiency of sphingomyaninase.

The substrate, sphingomyelin, builds up everywhere.

In neurons, yes, but also in phagocytic cells throughout the body.

So you get the cherry red spot in the neurodegeneration plus massive hepatosplenomegaly.

That is the key differentiator.

Under the electron microscope, the inclusions look different too, right?

They do.

In Tay -Sachs, you see lysosomes filled with these whorled membranes like an onion skin.

In Neiman Pick, you see zebra bodies or just foamy looking cells packed with lipid.

Okay.

What about Goucher disease?

The book says this is the most common lysosomal storage disorder.

It is.

This is a deficiency of glucocerebracidase.

And the substrate, glucocerebracide, accumulates in macrophages.

So what's the clinical picture?

The key here is bone involvement.

The bone marrow gets packed with these lipid -laden Goucher cells, which leads to bone pain, fractures, and even necrosis of the femoral head.

You also get hepatosplenomegaly.

And the appearance of those Goucher cells is classic.

Yes.

They are described as looking like crinkled tissue paper or crumpled silk under the microscope due to the arrangement of the lipid in the cytoplasm.

The book notes that type I, the adult form, accounts for 99 % of cases and doesn't involve the CNS.

And lastly for this group, the mucopolysaccharidosis or MPS disorders.

The text contrasts Hurler and Hunter syndromes.

They sound like a comedy duo, but they are very serious diseases caused by the inability to break down glycosaminoglycans or GAGs.

Let's start with Hurler or MPSI.

Hurler is the more severe of the two.

It's an autosomal recessive deficiency of IL -adronidase.

The GAGs build up everywhere.

This leads to corneal clouding, coarse facial features, described as gargoylism, hepatosplenomegaly, and developmental delay.

And Hunter syndrome, MPS II.

Hunter is generally milder.

The key differences are, one, it is X -linked recessive, not autosomal.

And two, crucially, there is no corneal clouding.

And there's a mnemonic for that.

There is.

Hunters need sharp eyes to aim, so they have clear corneas.

I love that mnemonic.

Okay, that wraps up a marathon of recessive diseases.

Let's switch gears to section six, autosomal dominant disorders.

Now we're talking about structural proteins and receptors.

And the first example is a perfect one.

Familial hypercholesterolemia.

It's a defect in the LDL receptor gene, LDLR, on chromosome 19.

So the receptor's job is to pull LDL cholesterol out of the blood and into the liver.

Exactly.

It's the check -in desk for cholesterol.

In this disease, the check -in desk is broken.

So LDL can't get into the liver cells, and its level in the blood skyrockets.

But it's a double whammy, isn't it?

It is.

Because the liver cells don't think they have any cholesterol inside, they do two things.

They put out even more LDL receptors trying to catch what's out there.

And they ramp up their own internal cholesterol synthesis via the enzyme HMG -CoA reductase.

So the loss of feedback inhibition.

A complete loss.

The result is massively high serum cholesterol from birth.

And what does that look like clinically?

You see xanthomas, which are these fatty lumps, particularly on the Achilles tendons, and xanthalasma, which are yellowish plaques around the eyelids.

But the real danger is premature aggressive atherosclerosis.

Heart attacks at a very young age.

Heterozygotes might have a heart attack in their 40s.

Homozygotes who have zero functional LDL receptors can have MIs in their teens or even as children.

Okay.

Next up, Marfan syndrome.

Marfan is a defect in the fibrillin 1 gene, FBN1, on chromosome 15.

What does fibrillin do?

Fibrillin is the protein that forms the scaffolding for elastic fibers.

It's what gives our connective tissues their strength and recoil.

Without normal fibrillin, your tissues are weak and floppy.

We all know the classic look.

Tall, thin, with long limbs, and arachnidactyly, the spider fingers.

But what actually kills these patients?

The aorta.

The wall of the aorta, which is rich in elastic fibers, becomes weak.

This is called cystic medial degeneration.

The wall can either balloon out into an aneurysm or it can tear, which is a life -threatening aortic dissection.

That's the major cause of death.

And what about the eyes?

Ectopialentus.

The ligaments holding the lens of the eye in place are also made of fibrillin, so they stretch and allow the lens to dislocate, usually upwards and outwards.

Then there's Ehlers -Danlos syndrome, or EDS.

EDS is a whole group of disorders, but they all share a common theme.

A defect in the structure or synthesis of collagen, the body's main structural protein.

So instead of floppy, the tissues are stretchy.

The classic findings are hyperextensible skin and hypermobile joints.

The book notes several variants, including a vascular type that is particularly dangerous because it can lead to the spontaneous rupture of arteries and organs.

Now for the neurocutaneous disorders.

Neurofibromatosis type 1.

NF1, or von Recklinghausen disease.

This is caused by a mutation in the NF1 gene on chromosome 17.

This gene codes for a tumor suppressor protein called neurofibromin.

And its job is to inhibit.

To inhibit P21 -RAFs, a key signaling protein that tells cells to grow and divide.

So when neurofibromin is broken, you get uncontrolled growth.

What are the clinical signs we need to look for, as shown in figure 6 -6?

It's a classic triad.

First, you look for multiple cafe au lait spots, which are flat, light brown skin macules that look like coffee stains.

Second, lish nodules, which are pigmented harmless growths on the iris that you need a slit lamp to see.

And third, the neurofibromas themselves, benign nerve sheath tumors that can appear as socked bumps on or under the skin.

And S2?

NF2 is caused by a mutation in the NF2 gene on chromosome 22.

It's a beautiful memory hook.

Type 2 is on chromosome 22 and it affects two ears.

Bilateral acoustic neuromas.

Bilateral vestibular schwannomas, to be precise.

These are tumors on the nerve of hearing and balance.

Finding them on both sides is diagnostic of NF2.

Finally, in this section, von Hippel -Lindau disease,

VHL.

This is a mutation in the VHL tumor suppressor gene on chromosome 3.

And the mechanism here is really cool.

It has to do with oxygen sensing.

It does.

The VHL protein's job is to tag another protein called HIF1 -alpha for destruction when there's plenty of oxygen around.

HIF1 -alpha is the panic button that turns on genes for blood vessel growth or angiogenesis.

So if VHL is broken?

The cell can't destroy HIF1 -alpha, so even in normal oxygen, the cell thinks it's starving and hypoxic.

It turns on angiogenesis and growth pathways constantly.

And this leads to specific tumors.

Yes.

You see hemangioblastomas tumors made of blood vessels in the retina and central nervous system.

You see cysts in the liver and kidneys.

And you have a very high risk of developing bilateral renal cell carcinoma.

Okay, section seven.

X -link conditions.

We've touched on the pattern.

Males are predominantly affected.

They get the gene from their carrier mothers and they can't pass it to their sons.

Right.

And the text lists a few key examples.

Lesch -Nihan syndrome is a tragic one.

Of the defect.

It's a deficiency of the enzyme HGPRT, which is involved in the purine salvage pathway.

When you can't salvage purines, your body just overproduces them and the breakdown product is uric acid.

So you get hyperuricemia.

Severe hyperuricemia leading to gout.

But the devastating part is the neurological symptoms.

Intellectual disability and this horrific compulsive self -mutilation biting their own lips and fingers off.

It's a terrible disease.

Testicular feminizations also mentioned.

That's the older name for androgen insensitivity syndrome.

We talked about this under DSDs.

It's a genetically male individual, 46 XY.

But they have defective androgen receptors.

So their body can't respond to testosterone.

So they develop as phenotypic females.

Yes, with female external genitalia.

But they have undescended tests in their abdomen and no uterus or fallopian tubes.

Brutal agammaglabula anemia.

This is a key immunodeficiency.

It's a defect in a tyrosine kinase called BTK, which is essential for B cell maturation.

No BTA, no mature B cells.

No B cells means no plasma cells.

And no plasma cells means no antibodies, no immunoglobulins.

So these boys get recurrent severe bacterial infections, usually starting around six months of age when their mother's protective antibodies wear off.

Okay, that brings it to the final section, section eight.

This is the grab bag of weird, non -Mendelian inheritance patterns.

It starts with triplet repeat mutations.

The stuttering genes.

This is a mechanism where a sequence of three DNA bases, like CGG, gets repeated over and over again.

And in some families, this repeat can get longer and longer with each generation.

The first example is fragile X syndrome.

This is a CGG repeat in a gene called FMR1 on the X chromosome.

After Down syndrome, this is the most common genetic cause of intellectual disability.

What's the phenotype?

The classic features, especially after puberty, are an elongated face with a large jaw, large averted ears, and most distinctively macro orchidism, which is large testes.

And Huntington disease.

Huntington is the classic autosomal dominant example.

Here the repeat is CAG in the Huntington gene HTT.

And this repeat is in the coding region.

It is.

So it gets translated into a long string of glutamine amino acids in the protein.

This makes the protein toxic.

It aggregates and kills neurons, specifically in the caudate nucleus of the brain.

Leading to the classic symptoms.

Caria, the uncontrollable, bounce -like movements, and a progressive dementia with an onset typically between ages 20 and 50.

And this disease shows anticipation.

It tends to start earlier and be more severe in successive generations as that CAG repeat gets longer.

Next up is genomic imprinting.

This is my favorite concept because it just breaks all the rules we learned from Mendel.

It really does.

The concept here is that for certain genes, it matters who you inherited the gene from, mom or dad.

One copy is epigenetically silenced or imprinted.

And the book gives the classic example.

The disorders linked to a micro deletion on chromosome 15, Prader -Willi and Angelman syndromes.

Right.

It's the exact same deletion of DNA, but the outcome is totally different depending on which parent's chromosome has the deletion.

So if the deletion is on the chromosome you inherited from your dad.

You get Prader -Willi syndrome.

This is characterized by severe hypotonia and infancy followed by the development of an insatiable appetite leading to obesity.

They also have hypogonadism and intellectual disability.

And if the exact same deletion is on the chromosome you got from your mom?

You get Angelman syndrome, a completely different disease.

They are known as the happy puppets because they have this happy demeanor with frequent inappropriate laughter.

They also have severe intellectual disability, seizures, and a taxic jerky gait.

Same DNA error, two different diseases.

It's incredible.

And briefly, let's touch on mitochondrial DNA disorders.

The key here is the inheritance pattern.

You get all of your mitochondria and therefore all of your mitochondrial DNA from your mother via the egg cytoplasm.

The sperm contributes none.

So it's maternal inheritance only.

Yes.

An affected mother passes the disorder to all of her children, both sons and daughters.

An affected father passes it to none of his children.

And the examples given.

Leber hereditary optic neuropathy, which causes a progressive bilateral loss of central vision.

And MERF, which stands for myoclonic epilepsy with ragged red fibers.

The ragged red fibers are seen on a muscle biopsy and represent mitochondria clumping under the cell membrane.

And finally, the chapter closes with multifactorial inheritance.

This is really how most common diseases work.

It's not a single gene.

It's the complex interplay of multiple genes, each with a small effect, plus environmental factors and lifestyle choices.

Type two diabetes.

Exactly.

Or hypertension, cleft lip and palate, neural tube defects.

It's nature and nurture working together.

Wow.

We have traversed the entire landscape of genetic pathology in chapter six.

From the massive visible trisomies all the way down to that single deleted amino acid in CF.

It's a lot, but if you focus on the mechanism, is it a broken enzyme, a faulty receptor, a weak structural protein?

It all starts to make sense.

The patterns emerge.

It's just amazing to think about how one tiny deletion, one little typo in a code that's three billion letters long can so completely change the entire trajectory of human life.

It really emphasizes the incredible precision of pathology.

It does.

It's a field of medicine with very little room for error.

Thank you so much for walking us through the blueprint today.

This was fantastic.

Always a pleasure to decode the mystery.

A warm thank you from the last minute lecture team.

Keep studying and we'll see you in the next deep dive.